Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference

    NEXT STORY
    RedHill Biopharma Announces New European and Japanese Patents for Talicia®
    PREV STORY
    Axsome Therapeutics Initiates MOMENTUM Phase 3 Trial of AXS-07 in Migraine
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immune Design Reports Third Quarter 2017 Financial Results and Provides Corporate Update

    SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Immune Design ...

    author_avatar
    NASDAQ Market News

    Sorrento Therapeutics Anti-CEA CAR-T Demonstrates Significant Therapeutic Activity With Increased Overall Survival in Pancreatic Cancer Patients With Liver Metastases

    Two out of four patients showed complete resolution of liver metastases on PET scanMedian ...

    author_avatar
    NASDAQ Market News

    FDA Approves G1 Therapeutics’ COSELA™ (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression

    author_avatar
    NASDAQ Market News